Dihydroartemisinin inhibits IL-6-induced epithelial–mesenchymal transition in laryngeal squamous cell carcinoma via the miR-130b-3p/STAT3/β-catenin signaling pathway

Dihydroartemisinin inhibits IL-6-induced epithelial–mesenchymal transition in laryngeal squamous cell carcinoma via the miR-130b-3p/STAT3/β-catenin signaling pathway

Objective To explore whether dihydroartemisinin (DHA) can block interleukin (IL)-6-induced epithelial–mesenchymal transition (EMT) in laryngeal squamous cell carcinoma (LSCC). Methods The expression of SLUG, signal transducer and activator of transcription 3 (STAT3), and microRNA (miR)-130b-3p was m...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yajing Sun, Xiuying Lu, Hui Li, Xiaoming Li
Formato: article
Lenguaje:EN
Publicado: SAGE Publishing 2021
Materias:
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/cb8a7bb368aa41fc9077f98c5913a329
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares